Bexa - 3x3x3 Challenge With Delia Napolitano
Discover Bexa, a revolutionary handheld device that detects abnormal breast tissue without discomfort. Bringing screenings to workplaces, we prioritize women's health with accessible, immediate care.
Transcript:
What is Bexa?
A few years ago, the statistic was 1 in 10 women, but today 1 in 8 women will be diagnosed with breast cancer. That is a huge shift. Clearly, the current system isn't reaching enough women. Mammograms, developed over 60 years ago, are still the gold standard, but here is the challenge: 6 out of 10 women skip them each year. Why? Discomfort, accessibility, fear. That means millions of women are being left behind and that is why we created Bexa. Bexa is an FDA-cleared handheld device that uses elastography to detect abnormal breast tissue using no radiation, no painful compression, and no long wait times. Our mission is simple: make breast health screens accessible, comfortable, and convenient. We're not here to replace mammograms. We're here to bridge the gap in care and make sure no woman is overlooked.
How is Bexa different?
So how is Bexa different? First, the technology itself, Bexa is a small portable device powered by 192 sensors that scan over the breast to detect abnormal tissue. But what truly sets us apart is how we bring screenings to women. We come directly to workplaces and create a spa-like experience where 95% of women are in and out within 30 minutes with immediate results. And for the 5% of women who may have a mass, we provide an onsite ultrasound, read by a radiologist, and reviewed by our chief medical officer within 24 to 48 hours. With traditional methods, this process could take weeks or even months. We're reducing both wait times and anxiety. When we look at the data, we see early detection saves lives. Catching cancer at stages one and two means higher survival rates. Catching it at stages three and four means a lower life expectancy and treatment cost exceeding $300,000 per patient. By making screening accessible, comfortable, and immediate, Bexa increases early detection and lowers unnecessary referrals.
Who is a good fit for Bexa?
Bexa is ideal for any employer who wants to prioritize women's health and proactively reduce cancer claims. Our solution works best for full-time in-office or hybrid workforces where employees can take advantage of convenient onsite screenings. We currently partner with industries across the board, including school districts, municipalities, and manufacturing. At the end of the day, Bexa isn't just about early detection, it's about accessibility, convenience, and peace of mind for the women in our workforce.
Transcript:
What is Bexa?
A few years ago, the statistic was 1 in 10 women, but today 1 in 8 women will be diagnosed with breast cancer. That is a huge shift. Clearly, the current system isn't reaching enough women. Mammograms, developed over 60 years ago, are still the gold standard, but here is the challenge: 6 out of 10 women skip them each year. Why? Discomfort, accessibility, fear. That means millions of women are being left behind and that is why we created Bexa. Bexa is an FDA-cleared handheld device that uses elastography to detect abnormal breast tissue using no radiation, no painful compression, and no long wait times. Our mission is simple: make breast health screens accessible, comfortable, and convenient. We're not here to replace mammograms. We're here to bridge the gap in care and make sure no woman is overlooked.
How is Bexa different?
So how is Bexa different? First, the technology itself, Bexa is a small portable device powered by 192 sensors that scan over the breast to detect abnormal tissue. But what truly sets us apart is how we bring screenings to women. We come directly to workplaces and create a spa-like experience where 95% of women are in and out within 30 minutes with immediate results. And for the 5% of women who may have a mass, we provide an onsite ultrasound, read by a radiologist, and reviewed by our chief medical officer within 24 to 48 hours. With traditional methods, this process could take weeks or even months. We're reducing both wait times and anxiety. When we look at the data, we see early detection saves lives. Catching cancer at stages one and two means higher survival rates. Catching it at stages three and four means a lower life expectancy and treatment cost exceeding $300,000 per patient. By making screening accessible, comfortable, and immediate, Bexa increases early detection and lowers unnecessary referrals.
Who is a good fit for Bexa?
Bexa is ideal for any employer who wants to prioritize women's health and proactively reduce cancer claims. Our solution works best for full-time in-office or hybrid workforces where employees can take advantage of convenient onsite screenings. We currently partner with industries across the board, including school districts, municipalities, and manufacturing. At the end of the day, Bexa isn't just about early detection, it's about accessibility, convenience, and peace of mind for the women in our workforce.